MYCN and neuroblastoma: Although the MYCN gene has been well characterized for its role as an oncogene in NB pathogenesis, the intriguing possibility remains whether co-amplified lncRNAs along with MYCN could additionally contribute to NB phenotype and thus could serve as potential biomarkers or drug targets.